Bill Text - SB289 (2022)

(New Title) relative to glucagon administration and relative to the dispenser report under the controlled drug prescription health and safety program.


Revision: Dec. 14, 2021, 2:15 p.m.

SB 289  - AS INTRODUCED

 

 

2022 SESSION

22-2984

05/11

 

SENATE BILL 289

 

AN ACT relative to glucagon administration.

 

SPONSORS: Sen. Sherman, Dist 24; Sen. Rosenwald, Dist 13; Sen. Bradley, Dist 3; Sen. Watters, Dist 4; Sen. Carson, Dist 14; Sen. Gray, Dist 6; Sen. D'Allesandro, Dist 20; Sen. Ward, Dist 8; Sen. Prentiss, Dist 5; Sen. Cavanaugh, Dist 16; Rep. Merchant, Sull. 4; Rep. Murphy, Graf. 12; Rep. Woods, Merr. 23; Rep. Knirk, Carr. 3; Rep. Marsh, Carr. 8

 

COMMITTEE: Health and Human Services

 

-----------------------------------------------------------------

 

ANALYSIS

 

This bill changes a statutory reference from glucagon injections to glucagon administration.

 

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

 

Explanation: Matter added to current law appears in bold italics.

Matter removed from current law appears [in brackets and struckthrough.]

Matter which is either (a) all new or (b) repealed and reenacted appears in regular type.

22-2984

05/11

 

STATE OF NEW HAMPSHIRE

 

In the Year of Our Lord Two Thousand Twenty Two

 

AN ACT relative to glucagon administration.

 

Be it Enacted by the Senate and House of Representatives in General Court convened:

 

1  Glucagon Administration.  Amend the section heading of RSA 22:40-b to read as follows:

200:40-b  Glucagon [Injections] Administration.

2  Effective Date.  This act shall take effect 60 days after its passage.